The has been a lot of experimental evidence resembling our results and those studies that proved that pharmacological or genetic induction of HO-1 in rodent models of obesity and diabetes decreased body weight and fasting blood glucose (10, 21–23). Here, HMOX1 is linked to obesity due to melanocortin 4 receptor deficiency.